(Total Views: 404)
Posted On: 04/19/2018 4:59:38 PM
Post# of 72446
Someone requested the links which I should’ve included.
Otezla’s Phase 2 Trial - https://clinicaltrials.gov/ct2/show/NCT007737...mp;rank=16
Phase 2 Results - https://www.businesswire.com/news/home/200912...ta-Celgene
Phase 3 Results - http://www.otezla.net/plaque-psoriasis/clinic...-endpoint/
O achieved 41% PASI 75 vs. 6% placebo in Phase 2. For some reasons its Phase 3 result was lower (33% vs. 5%).
Otezla’s Phase 2 Trial - https://clinicaltrials.gov/ct2/show/NCT007737...mp;rank=16
Phase 2 Results - https://www.businesswire.com/news/home/200912...ta-Celgene
Phase 3 Results - http://www.otezla.net/plaque-psoriasis/clinic...-endpoint/
O achieved 41% PASI 75 vs. 6% placebo in Phase 2. For some reasons its Phase 3 result was lower (33% vs. 5%).
(0)
(0)
